Pure Global AI
ANVISA registration 80020690348Valid until May 18, 2035

TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV)

ANVISA Registration Number: 80020690348BIO-RAD LABORATORIOS BRASIL LTDABIO-RADRisk Class IV
Verified
Device names
Technical name
TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV)
View exact technical-name matches →
PT: ANTICORPO TOTAL PARA VÍRUS DE HEPATITE C (ANTI-HCV)
Commercial name
Monolisa Anti-HCV PLUS Version 3
View exact commercial-name matches →
Risk class
Class IV
Registration details
Registration Number
80020690348
Process Number
25351655180201466
CNPJ
03188198000177
Company information
Registration Holder
BIO-RAD LABORATORIOS BRASIL LTDA
Manufacturer
BIO-RAD
Manufacturing Country
France
PT: FRANÇA
Dates and status
Publication Date
May 18, 2015
Validity
18/05/2035
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80020690348 and manufactured by BIO-RAD. The registration is held by BIO-RAD LABORATORIOS BRASIL LTDA with validity until May 18, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.